カテゴリ： MarketLine, オーストラリア, 企業調査

Coca-Cola Amatil Limited：企業の戦略・SWOT・財務情報

◆英語タイトル：Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3832
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：オーストラリア
◆産業分野：消費財
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Coca-Cola Amatil Limited – Strategy, SWOT and Corporate Finance Report
Summary

Coca-Cola Amatil Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Coca-Cola Amatil Limited (CCA or ‘the company’) is involved in manufacturing, distribution and marketing of carbonated soft drinks, spring water, sports and energy drinks, fruit juices, iced tea, flavored milk, coffee, tea, and ready-to-eat fruit and vegetable products. These products are marketed under the brands of Diet Coca Cola, Coca Cola Zero, Sprite, Fanta, Lift, and Kirks. It also manufactures and distributes beer, cider and spirits under the brands of Lift, Kirks, Cascade, Appletiser, Deep Spring, Barista, Zico, Fruit Box and Fuze Tea. The company operates in Australia, New Zealand, Fiji, Indonesia, Samoa and Papua New Guinea (PNG). CCA is headquartered in Sydney, New South Wales, Australia.

Scope

- Detailed information on Coca-Cola Amatil Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Coca-Cola Amatil Limited in the form of a SWOT analysis
- An in-depth view of the business model of Coca-Cola Amatil Limited including a breakdown and examination of key business segments
- Intelligence on Coca-Cola Amatil Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Coca-Cola Amatil Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Coca-Cola Amatil Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Coca-Cola Amatil Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Coca-Cola Amatil Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Coca-Cola Amatil Limited: Company Overview 9
Coca-Cola Amatil Limited: Overview and Key Facts 9
Coca-Cola Amatil Limited: Overview 9
Coca-Cola Amatil Limited: Key Facts 9
Coca-Cola Amatil Limited: Key Employees 10
Coca-Cola Amatil Limited: Key Employee Biographies 11
Coca-Cola Amatil Limited: Major Products and Services 15
Coca-Cola Amatil Limited: Company History 18
Coca-Cola Amatil Limited: Management Statement 22
Coca-Cola Amatil Limited: Locations and Subsidiaries 25
Coca-Cola Amatil Limited: Key Competitors 26
Coca-Cola Amatil Limited: Company Analysis 27
Coca-Cola Amatil Limited: Business Description 27
Coca-Cola Amatil Limited: SWOT Analysis 29
Coca-Cola Amatil Limited: SWOT Overview 29
Coca-Cola Amatil Limited: Strengths 29
Coca-Cola Amatil Limited: Weaknesses 30
Coca-Cola Amatil Limited: Opportunities 30
Coca-Cola Amatil Limited: Threats 31
Coca-Cola Amatil Limited: Corporate Financial Deals Activity 33
Coca-Cola Amatil Limited: Financial Deals Overview 33
Coca-Cola Amatil Limited: Targets and Partners 35
Coca-Cola Amatil Limited: Top Deals 2014 – 2018YTD* 36
Coca-Cola Amatil Limited: Advisors 37
Coca-Cola Amatil Limited: Top Legal Advisors 37
Coca-Cola Amatil Limited: Top Financial Advisors 37
Coca-Cola Amatil Limited: Mergers and Acquisitions 38
Coca-Cola Amatil Limited: Capital Raising 39
Coca-Cola Amatil Limited: Recent Developments 40
Coca-Cola Amatil Limited: News and Events Summary 40
Coca-Cola Amatil Limited: Business Expansion 44
Coca-Cola Amatil Limited: Contracts 45
Coca-Cola Amatil Limited: Corporate Governance 45
Coca-Cola Amatil Limited: Financial Deals 46
Coca-Cola Amatil Limited: Financial Performance 46
Coca-Cola Amatil Limited: Market Developments 47
Coca-Cola Amatil Limited: Strategy and Operations 47
Appendix 48
Contact Us 48
Methodology 48
About MarketLine 49

List of Tables
Table 1: Coca-Cola Amatil Limited: Key Facts
Table 2: Coca-Cola Amatil Limited: Key Employees
Table 3: Coca-Cola Amatil Limited: Locations and Subsidiaries
Table 4: Coca-Cola Amatil Limited: Key Competitors
Table 5: Coca-Cola Amatil Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Coca-Cola Amatil Limited: M&A Activity by Geography (TTM*)
Table 7: Coca-Cola Amatil Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Coca-Cola Amatil Limited: Targets and Partners
Table 9: Coca-Cola Amatil Limited: Top Deals 2014 - 2018YTD*
Table 10: Coca-Cola Amatil Limited: Legal Advisor Ranking by Value (US$m)
Table 11: Coca-Cola Amatil Limited: Financial Advisor Ranking by Value (US$m)
Table 12: Coca-Cola Amatil Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Coca-Cola Amatil Limited: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Coca-Cola Amatil Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Coca-Cola Amatil Limited: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Coca-Cola Amatil Limited: News and Events Summary
Table 17: Coca-Cola Amatil Limited: Business Expansion
Table 18: Coca-Cola Amatil Limited: Contracts
Table 19: Coca-Cola Amatil Limited: Corporate Governance
Table 20: Coca-Cola Amatil Limited: Financial Deals
Table 21: Coca-Cola Amatil Limited: Financial Performance
Table 22: Coca-Cola Amatil Limited: Market Developments
Table 23: Coca-Cola Amatil Limited: Strategy and Operations

List of Figures
Figure 1: Coca-Cola Amatil Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Coca-Cola Amatil Limited: M&A Activity by Geography (TTM*)
Figure 3: Coca-Cola Amatil Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Coca-Cola Amatil Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Coca-Cola Amatil Limited: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Coca-Cola Amatil Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Coca-Cola Amatil Limited: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Coca-Cola Amatil Limited：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Sunnybrook Research Institute：製薬・医療：M&Aディール及び事業提携情報
    Summary Sunnybrook Research Institute (SRI) an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate and doctoral degree programs. It provides research platforms for biological sciences, evaluative clinical sciences and physical …
  • Dauntless Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary Dauntless Pharmaceuticals Inc (Dauntless) is a biotech company that develops therapeutic agents. The company’s pipeline product include DP1038, a therapeutic agent used for the treatment of endocrine cancers. It operates through various stages of development. Dauntless manages the developmen …
  • Silmag SA：企業の製品パイプライン分析2018
    Summary Silmag SA (Silmag) is a manufacturer of biomedical products. The company offers products for vascular access, drainage, digestive tract, airway and urinary system. Its products include catheters, drainage tube, occlusion and identification tape, airway tube, double pigtail ureteral stent, cl …
  • Mitsubishi Corporation (8058)：電力：M&Aディール及び事業提携情報
    Summary Mitsubishi Corporation (Mitsubishi) is an integrated company that develops and operates businesses across industry including industrial finance, energy, metals, machinery, chemicals, living essentials, and environmental business. The company manufactures and markets a wide range of products, …
  • Pacific Textiles Holdings Ltd (1382)：企業の財務・戦略的SWOT分析
    Pacific Textiles Holdings Ltd (1382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Zynerba Pharmaceuticals Inc (ZYNE)-製薬・医療分野：企業M&A・提携分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz, Inc., focuses on the development of next-generation synthetic cannabinoid therapeutics. The company’s pipeline product candidates include ZYN002 and ZYN001. Zynerba’s ZYN002 is a synthetic CBD, a non-psychoactive canna …
  • Orchard Therapeutics Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Orchard Therapeutics Ltd (Orchard) is an integrated commercial-stage biotechnology company that develops gene therapies for the treatment of serious and life-threatening orphan diseases. Its pipeline products include Strimvelis, an autologous ex vivo gammaretroviral gene therapy for the trea …
  • Sky Deutschland GmbH：企業の戦略・SWOT・財務情報
    Sky Deutschland GmbH - Strategy, SWOT and Corporate Finance Report Summary Sky Deutschland GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Codiak BioSciences Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Codiak BioSciences Inc (Codiak BioSciences) is an exosome therapeutics company that focuses on the development of proprietary pipeline of targeted medicines for diseases with unmet medical needs. The company’s platform capitalizes on exosomes, which are nanometer-sized membrane sacs that del …
  • Aeroport Anapa OAO：戦略・SWOT・企業財務分析
    Aeroport Anapa OAO - Strategy, SWOT and Corporate Finance Report Summary Aeroport Anapa OAO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Clean Harbors Inc (CLH)：石油・ガス：M&Aディール及び事業提携情報
    Summary Clean Harbors Inc (Clean Harbors) is a provider of environmental, industrial and energy services. The company offers waste disposal and recycling, emergency response, chemical packing, field services, production services, exploration services, directional boring, lodging services and onsite …
  • Capitol Federal Financial, Inc：企業の戦略・SWOT・財務情報
    Capitol Federal Financial, Inc - Strategy, SWOT and Corporate Finance Report Summary Capitol Federal Financial, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Weifa ASA (WEIFA)-石油・ガス分野：企業M&A・提携分析
    Summary Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering p …
  • Lukoil Oil Co (LKOH)：企業の財務・戦略的SWOT分析
    Lukoil Oil Co (LKOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • NII Holdings, Inc.：企業の戦略・SWOT・財務情報
    NII Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary NII Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Oncolytics Biotech Inc (ONC)：医療機器：M&Aディール及び事業提携情報
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is indicated for the treatment of l …
  • ANS Group Plc：企業の戦略的SWOT分析
    ANS Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Endo International Plc (ENDP)：企業の財務・戦略的SWOT分析
    Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Vitae Pharmaceuticals Inc (VTAE)-製薬・医療分野：企業M&A・提携分析
    Summary Vitae Pharmaceuticals Inc (Vitae Pharmaceuticals) is a biopharmaceutical company that offers pharmaceutical products. The company discovers and develops and small molecule drugs for diseases with significant unmet medical needs. Its products pipeline includes VTP-34072, BI 1147560, VTP-43742 …
  • Aequus Pharmaceuticals Inc (AQS)：企業の財務・戦略的SWOT分析
    Summary Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Phar …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆